R89674 (generic name not yet established)

DRUG3 trials

Sponsors

Vistakon Pharmaceuticals

Conditions

Allergic ConjunctivitisHealthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

Phase 3

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

CompletedNCT00223951

Vistakon PharmaceuticalsHealthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

Start: 2005-09-30Target: 900Updated: 2015-02-20

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

CompletedNCT00241319

Vistakon PharmaceuticalsAllergic Conjunctivitis

Start: 2005-10-31Target: 150Updated: 2011-09-27

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

CompletedNCT00244543

Vistakon PharmaceuticalsAllergic Conjunctivitis

Start: 2005-10-31Target: 110Updated: 2011-09-27